SCHEMBL7777685

SCHEMBL7777685

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)n[nH]c2C(F)(F)C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 7/20 0.50
PTGS2 P35354 8/20 0.44
PTGS1 P23219 5/20 0.44
CA12 O43570 5/20 0.44
CA2 P00918 5/20 0.44
CA9 Q16790 5/20 0.44
CA1 P00915 4/20 0.44
CA3 P07451 3/20 0.44
CA6 P23280 3/20 0.44
CA5A P35218 3/20 0.44
CA7 P43166 3/20 0.44
CA5B Q9Y2D0 3/20 0.44
MAP2K7 O14733 1/20 0.43
MAP2K4 P45985 1/20 0.43
PDPK1 O15530 2/20 0.42
MT-CO2 P00403 2/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
ADRA2B P18089 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777620 0.90 LRRK2 (0.60) LRRK2PTGS2PTGS1CA12CA2
SCHEMBL7778222 0.89 PTGS2 (0.44) LRRK2PTGS2PTGS1CYP2C9
SCHEMBL7780727 0.88 LRRK2 (0.50) LRRK2PTGS2PTGS1CA12CA2
SCHEMBL7773229 0.88 LRRK2 (0.50) LRRK2PTGS2PTGS1CA12CA2
SCHEMBL8628165 0.81 LRRK2 (0.43) LRRK2
SCHEMBL7779772 0.79 LRRK2 (0.50) LRRK2PTGS2PTGS1CYP2C9
SCHEMBL7773326 0.79 LRRK2 (0.68) LRRK2PTGS2PTGS1CA12CA2
SCHEMBL7773014 0.79 LRRK2 (0.61) LRRK2PTGS2PTGS1CA12CA2
SCHEMBL7773204 0.78 PTGS2 (0.49) LRRK2PTGS2PTGS1
SCHEMBL7779616 0.78 LRRK2 (0.64) LRRK2PTGS2PTGS1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed